NCT05969002 2026-03-18
Pilot Prospective Study for PET-CT Imaging in Participants With Relapsed/Refractory Acute Leukemias
National Institutes of Health Clinical Center (CC)
Completed
Clinical Trials
577 trialsNCT01139476 2026-03-11
Specimen Collection for Agricultural Health Study Cohort Pesticide Exposure Study
National Institutes of Health Clinical Center (CC)
Completed
NCT07462962 2026-03-10
Effects of Mindfulness Meditation Training on Anxiety and Sleep Quality of Patients With Hematopoietic Stem Cell Transplantation During Admission in the Laminar Flow Chamber
Henan University
Completed
NCT06900114 2026-03-05
Disease Burden Transition of Mucormycosis in Hematologic Malignancies Population Across Covid 19 Era: a Single-center Comparative Analysis From China
Institute of Hematology & Blood Diseases Hospital, China
Completed
NCT03751072 2026-02-27
FRENCH-CYTO
Group for Research in Adult Acute Lymphoblastic Leukemia
Completed
NCT00339963 2026-02-20
Genome Expression in Lymphoma, Leukemia and Multiple Myeloma
National Institutes of Health Clinical Center (CC)
Completed
NCT05045963 2026-02-20
Impact of Aminoglycosides in Hypotensive Septic Oncology Patients
M.D. Anderson Cancer Center
Completed
NCT06565975 2026-02-12
RELION
Bristol-Myers Squibb
Completed
NCT03165851 2026-02-11
Efficacy Analysis of Comparison of CAMS（Chinese Academy of Medical Sciences）-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China
Completed
NCT06181734 2026-02-10
CONFIDHENCE
iOMEDICO AG
Completed
NCT04026737 2026-02-09
CVE-CART
Abramson Cancer Center at Penn Medicine
Completed
NCT06578351 2026-02-04
TRAM
Danone Asia Pacific Holdings Pte, Ltd.
Completed
NCT07374120 2026-02-02
Treatment Patterns and Key Endpoints Among Patients With Chronic-Phase Chronic Myeloid Leukemia in a Community Oncology Setting
Novartis
Completed
NCT07379528 2026-01-30
Mesenchymal Stem Cells in NPM1 Mutated Low Risk Acute Myeloid Leukemia: a Study of the Tumor Microenvironment and Its Contribution to the Outcome
Fondazione IRCCS Policlinico San Matteo di Pavia
Completed
NCT05622682 2026-01-26
VIRAL
Children's Hospital of Philadelphia
Completed
NCT00342888 2026-01-08
Case-Control Study of Pesticides and Childhood Leukemia
National Institutes of Health Clinical Center (CC)
Completed
NCT06395220 2026-01-02
Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation
Peking University People's Hospital
Completed
NCT04307134 2025-12-31
Besponsa Post Marketing Surveillance Study
Pfizer
Completed
NCT04679285 2025-12-23
FERTILAM
University Hospital, Lille
Completed
NCT04913038 2025-12-19
ANI-EP
University Hospital, Lille
Completed
NCT05215639 2025-12-10
VALOR
AbbVie
Completed
NCT05790538 2025-12-10
Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )
OHSU Knight Cancer Institute
Completed
NCT02949427 2025-12-05
The Oronasal Microbiota in Pediatric Oncology Patients
St. Jude Children's Research Hospital
Completed
NCT05923112 2025-12-05
BESPONSA Injection 1 mg Special Investigation
Pfizer
Completed
NCT04178317 2025-12-04
A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice
AbbVie
Completed
NCT03898128 2025-12-03
INO-CD22
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Completed
NCT06362044 2025-11-25
A Study to Assess Frequency of Undetectable Minimal Residual Disease (uMRD) in Adult Participants With Chronic Lymphocytic Leukemia (CLL) Receiving Oral Venetoclax Tablets ± Intravenously (IV) Infused Rituximab in Routine Clinical Practice in Japan
AbbVie
Completed
NCT03349931 2025-11-20
MYCOGENIE
Assistance Publique - Hôpitaux de Paris
Completed
NCT06143839 2025-11-20
VYSION
Jazz Pharmaceuticals
Completed
NCT02827617 2025-11-18
Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia
Oncology Institute of Southern Switzerland
Completed
NCT07200583 2025-11-18
PAIA-Haplo
Fujian Medical University
Completed
NCT06244147 2025-11-06
Long Term Safety and Efficacy of KSM-66 Ashwagandha in Adults
SF Research Institute, Inc.
Completed
NCT05018208 2025-10-30
Remote Monitoring in Cancer Care: A Platform Study
Mayo Clinic
Completed
NCT04188678 2025-10-27
REBOUND
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT04188912 2025-10-02
CATCH
Fred Hutchinson Cancer Center
Completed
NCT06449924 2025-10-01
An Endotracheal Tube Inserted to the Level of the Hypopharynx
American University of Beirut Medical Center
Completed
NCT05212233 2025-09-26
Financial Difficulty in Patients With Blood Cancer
UNC Lineberger Comprehensive Cancer Center
Completed
NCT07188428 2025-09-23
Treatment Patterns and Outcomes Among Patients With Chronic Myeloid Leukemia (CML) in All Lines of Treatment
Novartis
Completed
NCT05450367 2025-09-12
PRONOSTIM
Assistance Publique - Hôpitaux de Paris
Completed
NCT06734585 2025-09-12
Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell Transplant
Astellas Pharma Inc
Completed
NCT04872621 2025-09-02
Calquence CLL rr Japan PMS_Japan Post-Marketing Surveillance (PMS) Study - All Patient Investigation
AstraZeneca
Completed
NCT07150793 2025-09-02
A Study of Real-world Treatment and Burden of Chronic Myeloid Leukemia Patients in Japan
Novartis
Completed
NCT05123001 2025-08-29
Wearable Sensors and Molecular Omics to Detect and Mitigate Cell Therapy Adverse Events
Stanford University
Completed
NCT06648512 2025-08-26
EXCYTE-2
Exscientia AI Limited
Completed
NCT05964322 2025-07-31
RYTHMO'FIT
University Hospital, Montpellier
Completed
NCT04621851 2025-07-29
Retro-prospective Observational Study on Risk of Progression in CP-CML Patients Eligible for TKI Discontinuation
University of Milano Bicocca
Completed
NCT05549232 2025-07-23
Hypoxic Red Blood Cells for Burns and Hematological Malignancies at Haukeland University Hospital
Hemanext
Completed
NCT06659224 2025-07-23
The Risk of Acute Myeloid Leukaemia in Patients With Ewing's Sarcoma
Suez Canal University
Completed
NCT04589728 2025-07-08
Prospective and Retrospective Observational Evaluation of Real World Outcome of Unfit AML Patients Treated With the Combination Venetoclax Plus Hypomethylating Agents, Under the Italian Law No.648/96
Gruppo Italiano Malattie EMatologiche dell'Adulto
Completed
NCT05555979 2025-06-29
ELECTRIC
AbbVie
Completed